John V. W. Reynders
Director/Board Member at Rare-X
Network origin in John V. W. Reynders first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 96 | |
Rare-X
 Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023.
17
| Subsidiary | Packaged Software | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John V. W. Reynders via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BAXALTA INC | Biotechnology | Director/Board Member Human Resources Officer Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Public Communications Contact Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Investor Relations Contact Chief Tech/Sci/R&D Officer Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Compliance Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| ALLOVIR, INC. | Biotechnology | President Chairman General Counsel Director/Board Member Chief Tech/Sci/R&D Officer | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer General Counsel Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO Investor Relations Contact Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Director/Board Member Director/Board Member Corporate Officer/Principal | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Compliance Officer | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Comptroller/Controller/Auditor | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer General Counsel | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Public Communications Contact Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Chairman Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Biotechnology | Director/Board Member Chief Executive Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Masters Business Admin | |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Arradial, Inc. | Director/Board Member Corporate Officer/Principal | ||
| RALLYBIO CORPORATION | Biotechnology | Founder General Counsel | |
| Louisiana State University | College/University | Corporate Officer/Principal Doctorate Degree | |
| VOR BIOPHARMA INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| UNIQURE N.V. | Biotechnology | Director/Board Member Director/Board Member | |
LifeEDIT Therapeutics, Inc.
 LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ElevateBio LLC, LifeEDIT Therapeutics, Inc. is a next-generation genome editing company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company offers gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. LifeEDIT has a large and diverse library of RGNs, including type II and type V systems that encompass knock-out and knock-in capabilities, transcriptional regulation, and base editing when coupled with one of their proprietary deaminases. The company's nuclease collection has a broad range of protospacer adjacent motifs (PAMs), offering unprecedented access to genomes. LifeEDIT is headquartered in Morrisville, NC. The CEO of the company is Mitchell H. Finer. LifeEDIT Therapeutics was acquired by ElevateBio LLC from AgBiome Delta LLC on October 27, 2021. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Vanderbilt University | College/University | Undergraduate Degree Undergraduate Degree | |
| Colby College | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Yale School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| The Fuqua School of Business | College/University | Masters Business Admin Masters Business Admin | |
Biotechnology Research & Development Corp.
 Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Wiggin & Dana LLP
 Wiggin & Dana LLP Miscellaneous Commercial ServicesCommercial Services Wiggin & Dana LLP provides legal services. The firm’s client includes publicly traded companies, hospitals and other health care organizations, universities, entrepreneurs and emerging growth companies, real estate developers, financial institutions, museums, and charitable organizations and individuals. The company was founded in 1934 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Graduate Degree | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO Public Communications Contact | |
| VERISIGN. INC. | Internet Software/Services | Human Resources Officer Corporate Officer/Principal | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Director of Finance/CFO Chairman | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
BBI Diagnostics Group 2 Plc
 BBI Diagnostics Group 2 Plc Medical/Nursing ServicesHealth Services BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| ALERE INC | Medical Specialties | Compliance Officer General Counsel | |
| ACCELERON PHARMA INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 48 |
| Netherlands | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 12 |
| Commercial Services | 6 |
| Health Services | 4 |
| Finance | 2 |
Operational
| Director/Board Member | 330 |
| Corporate Officer/Principal | 240 |
| Independent Dir/Board Member | 124 |
| Undergraduate Degree | 75 |
| Director of Finance/CFO | 55 |
Most connected contacts
| Insiders | |
|---|---|
| Stephen P. Squinto | 40 |
| Felix Baker | 28 |
| Francois Nader | 28 |
| Martin MacKay | 28 |
| Rockford Norby | 28 |
| William Keller | 26 |
| M. Burns | 23 |
| Dave Anderson | 21 |
| Paul Friedman | 21 |
| Deborah Dunsire | 20 |
| Camille Bedrosian | 18 |
| Judith Reinsdorf | 18 |
| Bill Lundberg | 17 |
| Ellen Chiniara | 16 |
| Julie O'Neill | 16 |
- Stock Market
- Insiders
- John V. W. Reynders
- Company connections
